BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37864509)

  • 1. Population Pharmacokinetics of Atorvastatin in High-Altitude and Plain Patients with Hyperlipidemic.
    Li Y; Huang Q; Zeng X; Wang R; Li W
    J Clin Pharmacol; 2024 Mar; 64(3):345-352. PubMed ID: 37864509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a population pharmacokinetic model for atorvastatin acid and its lactone metabolite.
    Narwal R; Akhlaghi F; Asberg A; Hermann M; Rosenbaum SE
    Clin Pharmacokinet; 2010 Oct; 49(10):693-702. PubMed ID: 20818835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous LC-MS/MS analysis of simvastatin, atorvastatin, rosuvastatin and their active metabolites for plasma samples of obese patients underwent gastric bypass surgery.
    El-Zailik A; Cheung LK; Wang Y; Sherman V; Chow DS
    J Pharm Biomed Anal; 2019 Feb; 164():258-267. PubMed ID: 30396053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
    Fabre MA; Fuseau E; Ficheux H
    J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high-altitude environment on pharmacokinetic parameters of gliquidone in rats.
    Huang L; Zhang X; Luo L; Mu H; Li W; Wang R
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 51(4):389-396. PubMed ID: 37202102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus reduces the clearance of atorvastatin lactone: results of a population pharmacokinetic analysis in renal transplant recipients and in vitro studies using human liver microsomes.
    Dostalek M; Sam WJ; Paryani KR; Macwan JS; Gohh RY; Akhlaghi F
    Clin Pharmacokinet; 2012 Sep; 51(9):591-606. PubMed ID: 22775412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategies.
    Schipani A; Dickinson L; Boffito M; Austin R; Owen A; Back D; Khoo S; Davies G
    J Acquir Immune Defic Syndr; 2013 Jan; 62(1):60-6. PubMed ID: 23011396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: Application in a clinical pharmacokinetic study of single oral dose.
    Cestari RN; Rocha A; Marques MP; de Oliveira RDR; Lanchote VL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1126-1127():121766. PubMed ID: 31450089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats.
    Mahmoud MO; Aboud HM; Hassan AH; Ali AA; Johnston TP
    J Control Release; 2017 May; 254():10-22. PubMed ID: 28344015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection.
    Colombo S; Buclin T; Cavassini M; Décosterd LA; Telenti A; Biollaz J; Csajka C
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3801-8. PubMed ID: 16940065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intestinal flora on the pharmacokinetics and pharmacodynamics of aspirin in high-altitude hypoxia.
    Sun Y; Zhang J; Zhao A; Li W; Feng Q; Wang R
    PLoS One; 2020; 15(3):e0230197. PubMed ID: 32163488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different high altitudes on vascular endothelial function in healthy people.
    Fan N; Liu C; Ren M
    Medicine (Baltimore); 2020 Mar; 99(11):e19292. PubMed ID: 32176054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of lopinavir/ritonavir (Kaletra) in HIV-infected patients.
    López Aspiroz E; Santos Buelga D; Cabrera Figueroa S; López Galera RM; Ribera Pascuet E; Domínguez-Gil Hurlé A; García Sánchez MJ
    Ther Drug Monit; 2011 Oct; 33(5):573-82. PubMed ID: 21912331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced P-glycoprotein expression under high-altitude hypoxia contributes to increased phenytoin levels and reduced clearance in rats.
    Zhang J; Zhang M; Zhang J; Wang R
    Eur J Pharm Sci; 2020 Oct; 153():105490. PubMed ID: 32721527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic drug-drug interaction of Nomilin with atorvastatin in hyperlipidemic mice.
    Ding Y; Guan H; Yan Y; Chen Y; Huang C
    Heliyon; 2023 Nov; 9(11):e22016. PubMed ID: 38027676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of nifedipine in untreated and atorvastatin-treated hyperlipidemic rats.
    Eliot LA; Jamali F
    J Pharmacol Exp Ther; 1999 Oct; 291(1):188-93. PubMed ID: 10490903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients.
    Punyawudho B; Thammajaruk N; Ruxrungtham K; Avihingsanon A
    Int J Antimicrob Agents; 2017 Mar; 49(3):327-332. PubMed ID: 28109702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of plateau hypoxia on population pharmacokinetics and pharmacodynamics of metformin in patients with Type 2 diabetes.
    Shen Y; Luo X; Qin N; Hu L; Luo L; Wang Z; Sun Y; Wang R; Li W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 48(4):481-490. PubMed ID: 37385610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Lupus Erythematosus Activity Affects the Sinusoidal Uptake Transporter OATP1B1 Evaluated by the Pharmacokinetics of Atorvastatin.
    Cestari RN; de Oliveira RDR; de Souza FFL; Pippa LF; Nardotto GHB; Rocha A; Donadi EA; Lanchote VL
    Clin Transl Sci; 2020 Nov; 13(6):1227-1235. PubMed ID: 32463566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients.
    Li L; Wu H; Chen Y; Yuan H; Wu J; Wu X; Zhang Y; Cao G; Guo B; Wu J; Zhao M; Zhang J
    Clin Ther; 2020 May; 42(5):818-829. PubMed ID: 32389326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.